Cargando…
Differential outcomes of residual disease in surgically-resected non-small cell lung cancer and the importance of guideline-concordant adjuvant therapy
BACKGROUND: Positive mediastinal lymph nodes, a marker for systemic disease, and positive margins, a marker for local disease, following resection of non-small cell lung cancer (NSCLC) are forms of residual disease. The objective of this study is to compare survival of patients with residual disease...
Autores principales: | Lieu, Dustin K., Ding, Li, David, Elizabeth A., Wightman, Sean C., Atay, Scott M., McFadden, P. Michael, Kim, Anthony W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182525/ https://www.ncbi.nlm.nih.gov/pubmed/34164181 http://dx.doi.org/10.21037/jtd-21-110 |
Ejemplares similares
-
Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer
por: Wang, Jennifer C., et al.
Publicado: (2022) -
Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non–small cell lung cancer tumors
por: Peng, Terrance, et al.
Publicado: (2022) -
Enhanced Recovery After Surgery Protocol Minimizes Intensive Care Unit Utilization and Improves Outcomes Following Pulmonary Resection
por: Peng, Terrance, et al.
Publicado: (2021) -
Adjuvant chemotherapy, not radiotherapy, prolongs survival for node-negative non–small cell lung cancer with positive surgical margins
por: Ashrafi, Arman, et al.
Publicado: (2023) -
Surgical decision-making in advanced-stage non–small cell lung cancer is influenced by more than just guidelines
por: Peng, Terrance, et al.
Publicado: (2022)